Application of TRERNA1 gene to prediction and improvement of sensitivity of liver cancer drug sorafenib

A sorafenib and sensitive technology, applied in medical diagnosis and biological fields, can solve the problems of reducing the accuracy and effectiveness of chemotherapy treatment plans, and achieve the effect of simple and easy prediction and evaluation, high feasibility and simple introduction method.

Active Publication Date: 2018-12-21
SOUTHEAST UNIV
View PDF0 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] However, at present, there is no such curative effect prediction means and methods at home and abroad, which greatly reduces the accuracy and effectiveness of clinical postoperative treatment plans, especially chemotherapy treatment plans.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of TRERNA1 gene to prediction and improvement of sensitivity of liver cancer drug sorafenib

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0023] Example 1 CCK-8 Verification Method of TRERNA1 Expression and Sorafenib Resistance

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention belongs to the technical field of biology, particularly relates to the field of medical diagnosis, in particular to application of TRERNA1 gene to prediction and improvement of sensitivity of liver cancer drug sorafenib. The prognosis of hepatocellular carcinoma and the evaluation of chemotherapy resistance of liver cancer are marked, and the expression level of TRERNA1 genes is detected by utilizing an RNA in-situ hybridization technology or qPCR, so that the prognosis and chemotherapy resistance of the hepatocellular carcinoma can be obtained, the introduction way of the TRERNA1 is simple, the whole prediction and evaluation process is simple and easy, and the feasibility is high.

Description

technical field [0001] The invention belongs to the field of biotechnology, in particular to the field of medical diagnosis, and more specifically relates to the application of TRERNA1 gene in predicting and improving the chemotherapy sensitivity of hepatocellular carcinoma drug Sorafenib. Background technique [0002] Liver cancer is a malignant tumor of the liver, which can be divided into two categories: primary and secondary. Primary malignant tumors of the liver originate from the epithelial or mesenchymal tissues of the liver. The former is called primary liver cancer, which is a malignant tumor with a high incidence in my country and is extremely harmful; rare. [0003] The etiology and exact molecular mechanism of primary liver cancer are not yet fully understood. At present, it is believed that its pathogenesis is a multi-factor and multi-step complex process, which is affected by environmental and therefore dual factors. Epidemiological and experimental research d...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): C12Q1/6886A61K45/00A61P35/00
CPCA61K45/00A61P35/00C12Q1/6886C12Q2600/158C12Q2600/106C12Q2600/118
Inventor 樊红宋伟辜跃俊陆森李懿萍钱言言
Owner SOUTHEAST UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products